Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids.
Proost P, Verpoest S, Van de Borne K, Schutyser E, Struyf S, Put W, Ronsse I, Grillet B, Opdenakker G, Van Damme J. Proost P, et al. Among authors: schutyser e. J Leukoc Biol. 2004 May;75(5):777-84. doi: 10.1189/jlb.1003524. Epub 2004 Mar 2. J Leukoc Biol. 2004. PMID: 14996826
The CXC chemokine GCP-2/CXCL6 is predominantly induced in mesenchymal cells by interleukin-1beta and is down-regulated by interferon-gamma: comparison with interleukin-8/CXCL8.
Wuyts A, Struyf S, Gijsbers K, Schutyser E, Put W, Conings R, Lenaerts JP, Geboes K, Opdenakker G, Menten P, Proost P, Van Damme J. Wuyts A, et al. Among authors: schutyser e. Lab Invest. 2003 Jan;83(1):23-34. doi: 10.1097/01.lab.0000048719.53282.00. Lab Invest. 2003. PMID: 12533683 Free article.
Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies.
Proost P, Struyf S, Loos T, Gouwy M, Schutyser E, Conings R, Ronsse I, Parmentier M, Grillet B, Opdenakker G, Balzarini J, Van Damme J. Proost P, et al. Among authors: schutyser e. Arthritis Res Ther. 2006;8(4):R107. doi: 10.1186/ar1997. Arthritis Res Ther. 2006. PMID: 16846531 Free PMC article.
Stimulation of angiostatic platelet factor-4 variant (CXCL4L1/PF-4var) versus inhibition of angiogenic granulocyte chemotactic protein-2 (CXCL6/GCP-2) in normal and tumoral mesenchymal cells.
Vandercappellen J, Noppen S, Verbeke H, Put W, Conings R, Gouwy M, Schutyser E, Proost P, Sciot R, Geboes K, Opdenakker G, Van Damme J, Struyf S. Vandercappellen J, et al. Among authors: schutyser e. J Leukoc Biol. 2007 Dec;82(6):1519-30. doi: 10.1189/jlb.0407206. Epub 2007 Sep 7. J Leukoc Biol. 2007. PMID: 17827342
Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties.
Proost P, Schutyser E, Menten P, Struyf S, Wuyts A, Opdenakker G, Detheux M, Parmentier M, Durinx C, Lambeir AM, Neyts J, Liekens S, Maudgal PC, Billiau A, Van Damme J. Proost P, et al. Among authors: schutyser e. Blood. 2001 Dec 15;98(13):3554-61. doi: 10.1182/blood.v98.13.3554. Blood. 2001. PMID: 11739156 Free article.
Identification of biologically active chemokine isoforms from ascitic fluid and elevated levels of CCL18/pulmonary and activation-regulated chemokine in ovarian carcinoma.
Schutyser E, Struyf S, Proost P, Opdenakker G, Laureys G, Verhasselt B, Peperstraete L, Van de Putte I, Saccani A, Allavena P, Mantovani A, Van Damme J. Schutyser E, et al. J Biol Chem. 2002 Jul 5;277(27):24584-93. doi: 10.1074/jbc.M112275200. Epub 2002 Apr 26. J Biol Chem. 2002. PMID: 11978786 Free article.
26 results